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GII. All pts who Improved ejeslJon frastJon at folicw-up (28 in GI and 14 in GII) 
hed an early GADO washout in > 40% of the MRI defined myocard, Jm at 
dsk at baseline scan. The authors conclude that GADO enhanced MRI can 
effe,.'tively evaluate pts with Q wave and non-Q wave AMI, identifying pts at 
higher isk and predicting changes in global ejection fraction. This may give 
MRI a mere impartsnt role in the clinical investigation ofpts with AMI. 
~ Phase-conb'aat I~gnetic R~-qonan~ 
Angioglaphy: A New Approach in the Evaluation of 
Coronary LAD Artery Graft Patency and Flow 
Follswing Treatment of  LIMA Hypollerfusion 
Syndrome With Additional Vain Graft 
Gregor Zund, Markus Hauser, Paul Vogt, Jorg Oebatin, Ludwig K. von 
Segesser, Marko Turina. University Hospital, Zurich, Switzerland 
Pedoperative and early postoperative occlusion of a left internal mammary 
artew (LIMA) conduit may complicate myocardial revasculadzation leading 
to the potentially fatal LIMA hypoparfusion syndrome, Subsequent distal 
placement of a vein graft to the left anterior descending (LAD) artery may 
lead to concurrent or retrograde LIMA flow. The purpose of this study was 
to determine early and late postoperative flow rates in those patients who 
received LIMA and saphenous vein grafts to the LAD artery for treatment 
of LIMA hypoperfusion syndrome. Nineteen of twesty-ona patients who met 
this criteda were available for magnetic resonance imaging (MRI). Early (< 6 
months) and late (> 12 months} postoperative flow measurements of grafts 
were performed using conventional and a novel segment k-space phese- 
contrast MRI angiography technique. Early MRI controls revealed that all 
conduits had adapted to the coronary flow type with predominant diastolic 
perfusion. Patency rate at the eady and late control was 100%. Concurrent 
flow, flow reversal, or steal phenomena were absent. Mean flow rates were 
49.2 ml/mtn for the LiMA and 72.6 ml/min for the sephenous vein graft, 
respectively. Based on the Ilow data obtained with MRI angiography, the use 
of an additional sephenous vein graft as treatment of LIMA hypoparfusion 
syndrome does not lead to LIMA occlusion. Conduit flow adaptation to the 
diastolic predominance occurs in the first 6 months after operation. 
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~ Exercisc induced Ischemla in Myocardial 
Non-Obstructive Aneurysmatic Coronary Artery 
Disease Is Related to Coronary Diameters 
Dletrnar Kr0ger, Uldch Stiede, Abdolhamid Sheikhzadeh, 
Kad-Wemer Oladefich. Department of Cardiology, University LObeck, 
Germany 
Coronary aneurysms (CA) are defined as a dilatation of the coronary lumen 
> 1.5 fold of the normal diameter. CA are often associated with artsdoscta- 
rotic stenosis, the potency to cause a myocardial ischemia (C|) as a non- 
obstructive lesion with an impaired coronan] blood flow per se is discussed 
centroversialfy. 
Aim of the studywas to evaluate CI in patients (10is) with non-obstmative 
bilateral CA and to quantify its sevedty depending on the coronaly diameters. 
A coronary sinus lactate study with an incremental atrial pacing (CS) was 
performed in 31 pts, metabolic dteda for a CI were a reduction of the can:liac 
lactate extraction < l(P/o or a frank cardiac lactate production. Coronary 
angiographlas were screened for a segmental to and for movement and 
depots of dye known as angiographio stigmata of an impaired coronary 
circulation. 
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Results: 21/31 pts with CA developed an exercise induced CI in CS with a 
high correlation of the coronary diameters and the severity of CI (p < 0.003, 
r = 0.87) as depicted below for the left antenor descending coronary artery. 
All pts with a pathological cardiac lactate metabolism fudhermore presented 
with marked angiographic signs of an impaired coronary blood flow (p < 
0.02). 
Conclusions: Non-obstructive CA were identified as an entity of ischemic 
coronanj adery disease due to an impaired coronary blond flow. A signifi- 
cant correlation between the coronary diameters and the severity of CI was 
revealed. 
r~7~ Intravenous L-Arginine Restores Vascular 
Rsectivity in the Conduit Arteries of Young 
Hypercholesterolemic Adults 
Peter Clarkson, Ronald Hemy, Ann Donald, Amanda Powe, Teresa Bull, 
John Doantield. Great Orrnond Street Hospital NHS Trust, London, UK 
Hypercholastemlemia (HC) is associated with endothelial dysfunction in the 
microvasculature ofbeth asymptomatic young adults and in those subjects 
with clinical evidence of atherosclerosis. This may be reversed by intravenous 
(IV) L-arginine (L-arg), but the effects on conduit artedas have not been ex- 
amined. We studied vascular eactivity in 6 HC subjects and 6 centrols (LOL- 
cholasteml 2.25 4- 0.62 mmol/I vs 4.76 4- 0.75 retool/I, p < 0.005), all of whom 
(age 29.6 4- 2.3 yrs; range 22-36) were asymptometic, non-smokers, non 
hypertensive, non diabetic and on no cardiovascular medication. Fwe of the 
HC subjects had Familial HC and 3 were on dlolesteml Iowedng medication 
(Simvaststin). Using high resolution ulbasound, we measured brachial artery 
diameter at rest, in response to reactive hyperemia (endothelium-dependent 
dilation) and to sublingual glycory~dnitrate (endothelium-independent dila- 
tion). Row mediated ilation (FMD) was assessed before and after systemic 
infusion of L-arg (0.1 g/kg body weight) and the effect compared to a 5% 
dextrose (placebo) infusion. L-alg infusion resulted in a > 20 told increase 
in serum arginine levels without change in heart rate or blood pressure in 
any subject. L-arg produced no change in baseline vessel diameter in either 
group. However FMD, which was impaired in the HC subjects, improved 
after systemic administration ofL-arg (mean FMD from 1.1 + 0.7°/= to 3 9 ± 
0.8%; p < 0.001) compared to controls in whom there was no change (mean 
FMD from 3.6 4- 0.7% to 5.2 4- 0.9%; p = NS). No changes in FMO were 
observed after the placebo infusion and all subjects had dilation to GTN (HC 
19 -4- 4.6% vs 18 4-1.5% in the conlTois). Enhanced production or decreased 
breakdown of NO may mediate the improvement inEDD which occurs in HC 
but not in normal subjects following IV administration ofLoawg. This may be 
an important anti-athemgenic strategy if it can be achieved by chronic oral 
administration with L-arg. 
i ~ ' ]  Serum Levels of Vascular Endothelial Growth 
Factor (VEGF) Are Increased in Patients W'dh 
Acute Coronary lschemia 
Robert E. Fededci, Joseph A. Puma, William A. Baker, Stsven E. Heame, 
Donald E Forttn, Linda K. Shaw, Michael H, Sketch, Richard S. Slack, 
Robert M. Calilf, Kevin G. Peters. Duke Universi~, Durham, NC 
VEGF, a potent angiogenic protein, stimulates vascular growth in response 
to ischemia. If VEGF is important in the development of coliaterol blood ves- 
sels, we hypothesized that serum %E-GP tsvels would be elevated in patients 
with acute ischemtc syndromes. To evaluate this, we pm~fy  collected 
serum samples and measured VEGF levels in 89 patients undergoing car- 
diac catheterization. Patients wifll acute isd~mic syndmme~ (group 1, n = 
41), significant CAD without s ~  o1 acute ischem~ (group 2, n = 22) 
and no significant CAO (group 3, n = 33) were compared. Baseline char- 
actedstics were similar between the groups except for a higher incidence 
of chest pain, heparin use and history of myocardial infarction and a lower 
incidence oi congestive heart ta, ure in group 1. "The ~x:luenoy of coltaterais 
by angiographic ore lab analysis was 46%, 71% and 0% in the ~ groups. 
The serum VEGF levels were 7.3, 3.9 and 5.2 ng/ml respectively. 
i 
° t l , i l  
i 4.0 
i 
~1 group20ro~ 
Conc/us/on: Serum levels of VEGF are significanlfy higher in CAD pa- 
tients with acute ischemis yndromes. These findings suggest that VEGF is 
upregulated in CAD patients with acute ischemia. 
